|
Volumn 51, Issue 41, 2015, Pages 8626-8629
|
A platinum prodrug conjugated with a photosensitizer with aggregation-induced emission (AIE) characteristics for drug activation monitoring and combinatorial photodynamic-chemotherapy against cisplatin resistant cancer cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC METAL COMPLEX;
CISPLATIN;
PHOTOSENSITIZING AGENT;
PRODRUG;
VITRONECTIN RECEPTOR;
ANTINEOPLASTIC AGENT;
PLATINUM COMPLEX;
ANTIPROLIFERATIVE ACTIVITY;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RESISTANCE;
CELL VIABILITY;
CONTROLLED STUDY;
DRUG ACTIVATION;
DRUG CONJUGATION;
DRUG DESIGN;
DRUG SYNTHESIS;
ENDOCYTOSIS;
FLUORESCENCE;
IC50;
MCF 7 CELL LINE;
PHOTODYNAMIC THERAPY;
PROTEIN EXPRESSION;
CELL PROLIFERATION;
CELL SURVIVAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
DRUG EFFECTS;
DRUG RESISTANCE;
DRUG SCREENING;
HEK293 CELL LINE;
HUMAN;
PHOTOCHEMOTHERAPY;
STRUCTURE ACTIVITY RELATION;
TUMOR CELL LINE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CELL SURVIVAL;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE, NEOPLASM;
DRUG SCREENING ASSAYS, ANTITUMOR;
HEK293 CELLS;
HUMANS;
MCF-7 CELLS;
MOLECULAR STRUCTURE;
ORGANOPLATINUM COMPOUNDS;
PHOTOCHEMOTHERAPY;
PHOTOSENSITIZING AGENTS;
PRODRUGS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84929075421
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c5cc01952d Document Type: Article |
Times cited : (85)
|
References (34)
|